LumiraDx News

LMDXDelisted Stock  USD 0.42  0.02  4.55%   
Slightly above 61% of LumiraDx's investor base is looking to short. The analysis of current outlook of investing in LumiraDx suggests that many traders are alarmed regarding LumiraDx's prospects. LumiraDx's investing sentiment can be driven by a variety of factors including economic data, LumiraDx's earnings reports, geopolitical events, and overall market trends.
  
over six months ago at news.google.com         
LumiraDx 10K Form and SEC Filings 2024 - MarketBeat
Google News at Macroaxis
over six months ago at investorplace.com         
Why Is LumiraDx Stock Down 13 percent Today?
sbwire news
over six months ago at investorplace.com         
Why Is Spirit AeroSystems Stock Down 14 percent Today?
sbwire news
over six months ago at benzinga.com         
LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business o...
benzinga news
over six months ago at seekingalpha.com         
LumiraDx says its securities will be suspended from trading on Nasdaq
seekingalpha News
over six months ago at investing.com         
LumiraDx to be delisted from Nasdaq on January 9
Investing News at Macroaxis
over six months ago at seekingalpha.com         
LumiraDx stock falls on MA deal with Roche
seekingalpha News
over six months ago at zacks.com         
Roche to Acquire LumiraDxs Point of Care Technology
zacks News
over six months ago at seekingalpha.com         
LumiraDx to sell its point of care technology platform to Roche
seekingalpha News
over six months ago at globenewswire.com         
LumiraDx Announces Agreement to Sell itsCutting Edge Point of Care Technology Platform to Roche
Macroaxis News: globenewswire.com
over six months ago at benzinga.com         
LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
benzinga news
over six months ago at news.google.com         
5 Hot Healthcare Stocks To Buy Now - Insider Monkey
Google News at Macroaxis
over a year ago at simplywall.st         
Market Cool On LumiraDx Limiteds Revenues Pushing Shares 27 percent Lower
Simply Wall St News at Macroaxis
over a year ago at news.google.com         
BioPharma Credit notes loan agreement amendment by LumiraDx - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Todays Biggest Pre-Market Stock Movers 10 Top Gainers and ... - Nasdaq
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about LumiraDx that are available to investors today. That information is available publicly through LumiraDx media outlets and privately through word of mouth or via LumiraDx internal channels. However, regardless of the origin, that massive amount of LumiraDx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of LumiraDx news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of LumiraDx relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to LumiraDx's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive LumiraDx alpha.

LumiraDx Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
LumiraDx Submits Dual FDA Medical Device Application for Covid-19 Test
06/30/2023
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Consideration for investing in LumiraDx Stock

If you are still planning to invest in LumiraDx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx's history and understand the potential risks before investing.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Money Managers
Screen money managers from public funds and ETFs managed around the world